(Q37615367)

21 August 2017

1 reference

title

The glycobiology of brain tumors: disease relevance and therapeutic potential (English)

1 reference

21 August 2017

0 references

1 reference

Joseph R Moskal

1

1 reference

PubMed ID

19831842

21 August 2017

Roger A Kroes

series ordinal

2

1 reference

PubMed ID

19831842

21 August 2017

Glyn Dawson

series ordinal

3

1 reference

21 August 2017

1 October 2009

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

21 August 2017

1 reference

21 August 2017

9

1 reference

21 August 2017

10

1 reference

21 August 2017

1529-1545

1 reference

21 August 2017

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Glycosylation defining cancer malignancy: new wine in an old bottle

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Gangliosides of human cerebral astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Occurrence of lacto series gangliosides 3'-isoLM1 and 3',6'-isoLD1 in human gliomas in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Glycosphingolipid component profiles of human gliomas correlate with histological tumour types: analysis of inter-individual and tumour-regional distribution.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Ganglioside composition and its relation to clinical data in brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Ganglioside patterns in neuroepithelial tumors of childhood.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Human medulloblastoma gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Molecular markers that identify human astrocytomas and oligodendrogliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

GT1b in human metastatic brain tumors: GT1b as a brain metastasis-associated ganglioside

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Detection of medulloblastoma and astrocytoma-associated ganglioside GD3 in cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Ganglioside GD3 shedding by human gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Structural characterization and in vivo immunosuppressive activity of neuroblastoma GD2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

CD44 adhesion molecule and neuro-glial proteoglycan NG2 as invasive markers of glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Expression of the neural cell adhesion molecule in astrocytic tumors: an inverse correlation with malignancy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Correlation of N-cadherin expression in high grade gliomas with tissue invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Relationship between the expression of E-, N-cadherins and beta-catenin and tumor grade in astrocytomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Galectin-1 is highly expressed in human gliomas with relevance for modulation of invasion of tumor astrocytes into the brain parenchyma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Role of galectin-1 in migration and invasion of human glioblastoma multiforme cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Galectins - potential targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Integrins: molecular targets in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Regulation of integrin functions by N-glycans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Branched N-glycans regulate the biological functions of integrins and cadherins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

A novel membrane-associated glycovariant of BEHAB/brevican is up-regulated during rat brain development and in a rat model of invasive glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Novel tumor-specific isoforms of BEHAB/brevican identified in human malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Epidermal growth factor receptor - mediated signal transduction in the development and therapy of gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Genetic and signaling pathway alterations in glioblastoma relevance to novel targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Inhibition of a specific N-glycosylation activity results in attenuation of breast carcinoma cell invasiveness-related phenotypes: inhibition of epidermal growth factor-induced dephosphorylation of focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Core fucosylation regulates epidermal growth factor receptor-mediated intracellular signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

A phase I clinical trial with monoclonal antibody ch806 targeting transitional state and mutant epidermal growth factor receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Role of gangliosides in tumour progression: a molecular target for cancer therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Glioma heterogeneity in vitro: the significance of growth factors and gangliosides

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Genetic variation of human UDP-glucuronosyltransferase: implications in disease and drug glucuronidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

GnT-V, macrophage and cancer metastasis: a common link

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Sialyltransferases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Inhibitors of sialyltransferases: potential roles in tumor growth and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

The expression of Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase and alpha 2,6-linked sialoglycoconjugates in human brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

alpha2,3-sialyltransferase mRNA and alpha2,3-linked glycoprotein sialylation are increased in malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Transfection of 2,6 and 2,3-sialyltransferase genes and GlcNAc-transferase genes into human glioma cell line U-373 MG affects glycoconjugate expression and enhances cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Over-expression of beta-1,4-galactosyltransferase I, II, and V in human astrocytoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Ganglioside GM2/GD2 synthetase mRNA is a marker for detection of infrequent neuroblastoma cells in bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Selectins: a family of adhesion receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Proteoglycans: structures and interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Phase I clinical trial on adjuvant active immunotherapy of human gliomas with GD2-conjugate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Ganglioside GM3 inhibits proliferation and invasion of glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

GD1alpha-replica peptides functionally mimic GD1alpha, an adhesion molecule of metastatic tumor cells, and suppress the tumor metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Functionalized glycomers as growth inhibitors and inducers of apoptosis in human glioblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Purification and structure of neurostatin, an inhibitor of astrocyte division of mammalian brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Novel disaccharide inhibitors of human glioma cell division.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Neurostatin: cellular sources and cellular targets of the inhibitor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

The animal sialyltransferases and sialyltransferase-related genes: a phylogenetic approach.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

The human sialyltransferase family

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Regulation of sialyltransferase expression by estradiol and 4-OH-tamoxifen in the human breast cancer cell MCF-7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Expression of sialyl-Tn antigen in breast cancer cells transfected with the human CMP-Neu5Ac: GalNAc alpha2,6-sialyltransferase (ST6GalNac I) cDNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Role of the human ST6GalNAc-I and ST6GalNAc-II in the synthesis of the cancer-associated sialyl-Tn antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Glycosyltransferase and sialic acid levels of normal and transformed cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Biological roles of oligosaccharides: all of the theories are correct

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Surface glycoproteins of normal and transformed cells: a difference determined by sialic acid and a growth-dependent sialyl transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Modulation of K562 cells with sodium butyrate. Association of impaired NK susceptibility with sialic acid and analysis of other parameters.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Effect of desipramine on a glycoprotein sialyltransferase activity in C6 cultured glioma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Study of O-glycan sialylation in C6 cultured glioma cells: evidence for post-translational regulation of a beta-galactoside alpha 2,3 sialyltransferase activity by N-glycosylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Effect of retinoic acid on two glycosyltransferase activities in C6 cultured glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Alterations in serum sialyltransferase activities in patients with brain tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

The expression of CMP-NeuAc: Gal beta 1,4GlcNAc alpha 2,6 sialyltransferase [EC 2.4.99.1] and glycoproteins bearing alpha 2,6-linked sialic acids in human brain tumours.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Looking beyond morphology: cancer gene expression profiling using DNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Microarray applications in neuroscience

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Advantages and limitations of microarray technology in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Glycosyltransferase expression in human colonic tissue examined by oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Modeling depression: social dominance-submission gene expression patterns in rat neocortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Fundamentals of experimental design for cDNA microarrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Focused microarray analysis of glyco-gene expression in human glioblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

DNA hypomethylation leads to elevated mutation rates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

DNA methyltransferases control telomere length and telomere recombination in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

The DNMT3B DNA methyltransferase gene is mutated in the ICF immunodeficiency syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

DNA methylation in brain development and gliomagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Methylation profiles of genomic DNA of mouse developmental brain detected by restriction landmark genomic scanning (RLGS) method

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

The impact of L1 retrotransposons on the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Targeted mutation of the DNA methyltransferase gene results in embryonic lethality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

DNA methylation is a critical cell-intrinsic determinant of astrocyte differentiation in the fetal brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Altered methylation patterns in cancer cell genomes: cause or consequence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Worms gang up on bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

DNA hypermethylation contributes to incomplete synthesis of carbohydrate determinants in gastrointestinal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Conditionally replicative adenoviral vectors for malignant glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Preclinical Characterization of the Antiglioma Activity of a Tropism-Enhanced Adenovirus Targeted to the Retinoblastoma Pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Sweet and sour: the impact of sugars on disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Glycosylation as a strategy to improve antibody-based therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

Growing Y-junction carbon nanotubes

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2FERN.09.105

21 January 2018

Identifiers

DOI

10.1586/ERN.09.105

1 reference

21 August 2017

1 reference

PubMed ID

19831842